Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geoffrey A Block

Showing results (61-70 of 117) with videos related to

Pageof 12
Sort By:
American Journal of Nephrology|December 20, 2015
Treatment of Secondary Hyperparathyroidism: Results of a Phase 2 Trial Evaluating an Intravenous Peptide Agonist of the Calcium-Sensing ReceptorDavid A Bushinsky, Geoffrey A Block, Kevin J Martin, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 20, 2018
Effects of vadadustat on hemoglobin concentrations in patients receiving hemodialysis previously treated with erythropoiesis-stimulating agentsVolker H Haase, Glenn M Chertow, Geoffrey A Block, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 15, 2013
Phosphate homeostasis in CKD: report of a scientific symposium sponsored by the National Kidney FoundationGeoffrey A Block, Joachim H Ix, Markus Ketteler, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 13, 2019
One-year safety and efficacy of intravenous etelcalcetide in patients on hemodialysis with secondary hyperparathyroidismDavid A Bushinsky, Glenn M Chertow, Sunfa Cheng, et al.
American Journal of Nephrology|July 7, 2024
A Randomized Trial of the Impact of Ferric Citrate on Erythropoietin and Intravenous Iron Use in Patients Receiving DialysisGeoffrey A Block, Mohammed Reza Mizani, Varshasb Broumand, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 25, 2016
Effect of Tenapanor on Interdialytic Weight Gain in Patients on HemodialysisGeoffrey A Block, David P Rosenbaum, Maria Leonsson-Zachrisson, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 22, 2026
Dialysis Facility Closures in the US From 2018 to 2024: A Serial Cross-Sectional StudyMeri R J Varkila, Maria Montez-Rath, Xue Yu, et al.
JAMA Network Open|July 26, 2023
Use of Wastewater Metrics to Track COVID-19 in the USMeri R J Varkila, Maria E Montez-Rath, Joshua A Salomon, et al.
Clinical Journal of the American Society of Nephrology : CJASN|September 29, 2016
Effect of Patiromer on Urinary Ion Excretion in Healthy AdultsDavid A Bushinsky, David M Spiegel, Coleman Gross, et al.
BMC Nephrology|November 6, 2016
Facility-level CKD-MBD composite score and risk of adverse clinical outcomes among patients on hemodialysisGeoffrey A Block, Akeem A Yusuf, Mark D Danese, et al.
Pageof 12

Showing results (61-70 of 117) with videos related to

Sort By:
Pageof 12
American Journal of Nephrology|December 20, 2015
Treatment of Secondary Hyperparathyroidism: Results of a Phase 2 Trial Evaluating an Intravenous Peptide Agonist of the Calcium-Sensing ReceptorDavid A Bushinsky, Geoffrey A Block, Kevin J Martin, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 20, 2018
Effects of vadadustat on hemoglobin concentrations in patients receiving hemodialysis previously treated with erythropoiesis-stimulating agentsVolker H Haase, Glenn M Chertow, Geoffrey A Block, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 15, 2013
Phosphate homeostasis in CKD: report of a scientific symposium sponsored by the National Kidney FoundationGeoffrey A Block, Joachim H Ix, Markus Ketteler, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 13, 2019
One-year safety and efficacy of intravenous etelcalcetide in patients on hemodialysis with secondary hyperparathyroidismDavid A Bushinsky, Glenn M Chertow, Sunfa Cheng, et al.
American Journal of Nephrology|July 7, 2024
A Randomized Trial of the Impact of Ferric Citrate on Erythropoietin and Intravenous Iron Use in Patients Receiving DialysisGeoffrey A Block, Mohammed Reza Mizani, Varshasb Broumand, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 25, 2016
Effect of Tenapanor on Interdialytic Weight Gain in Patients on HemodialysisGeoffrey A Block, David P Rosenbaum, Maria Leonsson-Zachrisson, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 22, 2026
Dialysis Facility Closures in the US From 2018 to 2024: A Serial Cross-Sectional StudyMeri R J Varkila, Maria Montez-Rath, Xue Yu, et al.
JAMA Network Open|July 26, 2023
Use of Wastewater Metrics to Track COVID-19 in the USMeri R J Varkila, Maria E Montez-Rath, Joshua A Salomon, et al.
Clinical Journal of the American Society of Nephrology : CJASN|September 29, 2016
Effect of Patiromer on Urinary Ion Excretion in Healthy AdultsDavid A Bushinsky, David M Spiegel, Coleman Gross, et al.
BMC Nephrology|November 6, 2016
Facility-level CKD-MBD composite score and risk of adverse clinical outcomes among patients on hemodialysisGeoffrey A Block, Akeem A Yusuf, Mark D Danese, et al.
Pageof 12